Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1999 Oct;45(4):564-9.
doi: 10.1136/gut.45.4.564.

The sigma ligand, igmesine, inhibits cholera toxin and Escherichia coli enterotoxin induced jejunal secretion in the rat

Affiliations

The sigma ligand, igmesine, inhibits cholera toxin and Escherichia coli enterotoxin induced jejunal secretion in the rat

J L Turvill et al. Gut. 1999 Oct.

Abstract

Background: Cholera toxin, and Escherichia coli heat labile (LT) and heat stable (STa) enterotoxins induce small intestinal secretion in part by activating enteric nerves. Igmesine is a novel sigma receptor ligand that inhibits neurally mediated secretion.

Aims: To assess the antisecretory potential of igmesine in cholera toxin, LT, and STa induced water and electrolyte secretion using an in vivo rat model of jejunal perfusion.

Methods: After pretreatment with igmesine, 0.03-10 mg/kg intravenously, jejunal segments of anaesthetised, adult male Wistar rats were incubated with cholera toxin (25 microg), LT (25 microg), or saline. Jejunal perfusion with a plasma electrolyte solution containing a non-absorbable marker was undertaken. In some cases 200 microg/l STa was added to the perfusate. After equilibration, net water and electrolyte movement was determined. In additional experiments rats received igmesine, intravenously or intrajejunally, after exposure to cholera toxin.

Results: Cholera toxin induced net water secretion was inhibited by 1 mg/kg igmesine (median -120 versus -31 microl/min/g, p<0.001). LT and STa induced secretion were also inhibited by 1 mg/kg igmesine (-90 versus -56, p<0.03; and -76 versus -29, p<0.01, respectively). Igmesine reduced established cholera toxin induced secretion.

Conclusion: The sigma ligand, igmesine, inhibits neurally mediated enterotoxigenic secretion. Its ability to inhibit established secretion makes it an agent with therapeutic potential.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Effect of pretreatment with igmesine on cholera toxin (CT) induced jejunal net water secretion. Data expressed as median and interquartile range. *p<0.04 compared with CT; †p<0.02 compared with CT + 0.03 mg/kg igmesine (Kruskal-Wallis).
Figure 2
Figure 2
Effect of igmesine (1 mg/kg intravenously) on established cholera toxin induced jejunal net water secretion. Net water secretion in individual rats (n=12) is represented at 45 minutes (pre-igmesine) and at 75 minutes (post-igmesine). p<0.04 compared with cholera toxin alone (Mann-Whitney test).
Figure 3
Figure 3
Effect of the addition of igmesine (40 µg/ml) to the perfusate, on established cholera toxin induced jejunal net water secretion. Net water secretion in individual rats (n=8) is represented on equilibration at 45 minutes and after receiving 6 mg/kg igmesine, intrajejunally, at 75 minutes. p<0.002 compared with cholera toxin perfused with standard plasma electrolyte solution (Mann-Whitney test).
Figure 4
Figure 4
Effect of pretreatment with igmesine (1 mg/kg intravenously) on heat labile (LT) and heat stable (STa) enterotoxin induced jejunal net water secretion. Data expressed as median and interquartile range. †p<0.03 compared with LT; **p<0.01 compared with STa (Mann-Whitney test).

References

    1. Eur J Pharmacol. 1997 Aug 20;333(1):87-92 - PubMed
    1. Gut. 1995 Sep;37(3):340-5 - PubMed
    1. Gastroenterology. 1998 Oct;115(4):883-90 - PubMed
    1. J Pharmacol Exp Ther. 1976 Jun;197(3):517-32 - PubMed
    1. J Infect Dis. 1976 Aug;134(2):135-43 - PubMed

Publication types